HomeNewsIndiaNo plan for lockdown or mini-lockdown in national capital: Delhi Deputy CM Manish Sisodia

No plan for lockdown or mini-lockdown in national capital: Delhi Deputy CM Manish Sisodia

Manish Sisodia's statement comes a day after Delhi Health Minister Satyendar Jain said there is no chance of re-imposition of lockdown in the national capital.

November 17, 2020 / 19:34 IST
Story continues below Advertisement

Deputy Chief Minister of Delhi Manish Sisodia on November 17 told CNBC-TV18 that there is no plan for a lockdown or a "mini-lockdown" in the national capital despite the growing number of COVID-19 cases.

Story continues below Advertisement

Sisodia also said that recent festivals caused crowding at markets in the city and that he expects the cases to go down once the festival season winds up.

"Delhi government has only asked for an exemption from Home Ministry rules to reduce crowding at markets," Sisodia said, adding that the government will look to curb crowds at markets subject to tests and positivity rates.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show